Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of RALGDS mRNA | affects expression | 21346803
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of RALGDS mRNA | decreases expression | 12419474
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RALGDS mRNA | affects expression | 17562736
|
D000499 |
Allylamine |
Allylamine affects the expression of RALGDS mRNA | affects expression | 15910882
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RALGDS mRNA | affects expression | 16483693
|
D002118 |
Calcium |
Calcium affects the expression of RALGDS mRNA | affects expression | 15913539
|
D002713 |
Chlorine |
Chlorine results in increased expression of RALGDS mRNA | increases expression | 18636392
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in increased expression of RALGDS mRNA | affects cotreatment|increases expression | 18636392
|
C014347 |
decitabine |
decitabine affects the expression of RALGDS mRNA | affects expression | 17145863
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of RALGDS mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of RALGDS mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RALGDS mRNA | affects cotreatment|increases expression | 17942748
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RALGDS mRNA | affects cotreatment|increases expression | 17183730
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in increased expression of RALGDS mRNA | affects cotreatment|increases expression | 18636392
|
C488333 |
Ro 65-7199 |
Ro 65-7199 affects the expression of RALGDS mRNA | affects expression | 14610520
|
C488334 |
Ro 66-0074 |
Ro 66-0074 affects the expression of RALGDS mRNA | affects expression | 14610520
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of RALGDS mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RALGDS mRNA | affects cotreatment|increases expression | 17942748
|
C402769 |
tipifarnib |
tipifarnib results in decreased expression of RALGDS mRNA | decreases expression | 16403772
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RALGDS mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.28 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.28 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.94 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
4.31 | 20601635 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.81 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.37 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.43 | 15513908 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.23 | 17688650 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.09 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.84 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.55 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.45 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.65 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.55 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.63 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 17507914 17688650 15238991 19460635 18316065 18940202 17157402 18775368 20603192 16609825 18177632 18558336 19232924 18985861 18396377 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.06 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.02 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.98 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.98 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.87 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.87 | 17893378 18821012 20135344 19103187 19084267 18997820 18629630 16873071 19155303 19200415 18351453 16818667 11161223 17261762 19011961 21152245 19142967 19410462 18855134 20544844 18815881 17440819 19059307 19189210 16202921 21138602 19189212 19115204 19221464 17242785 19244106 20005174 16273361 18425577 18984771 20390343 19289846 20859285 19066611 15565566 19288272 17049068 19487384 15668708 20065188 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.66 | 16777450 18315731 14754758 17626835 19059883 18417511 15516495 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.73 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.49 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.50 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.50 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.50 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.59 | 19215824 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.60 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.57 | 10977129 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.70 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.86 | 11677210 16105132 15861022 16919318 17333356 17681005 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.09 | 15340226 12621046 8697196 16354765 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.33 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.47 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.47 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.00 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.35 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.46 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.90 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.90 | 18071297 19739265 14550746 17522070 16393943 11287661 17562736 19164858 10663392 12958197 15619225 2444490 19370779 11421492 16781746 11834606 11529661 19085960 11739529 19923254 11461765 10915739 11743745 16109766 12392966 14986274 14725611 16081117 19416960 16227642 12540782 17906064 10774834 15968718 12153990 12594235 19420014 16177239 18713872 16485898 12705907 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.90 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
8.90 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.10 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.74 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.62 | 20016425 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.03 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.36 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.90 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.89 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.89 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.12 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.03 | 20544844 17893378 19155303 16202921 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.14 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.92 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.92 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.57 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.28 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.06 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.01 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
13.01 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.01 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.22 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.89 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.11 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.52 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.17 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.93 | 20067830 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
5.01 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.68 | 16983495 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.47 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.32 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.88 | 15340226 16120746 12621046 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.86 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 15340226 18606429 16959395 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.68 | 16870215 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.90 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.61 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.80 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.44 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.67 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.67 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.85 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.85 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.32 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.19 | 12587719 15629191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.33 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.33 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.05 | 16316344 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.06 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.98 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.98 | 18460780 18206229 18704418 19010910 17679729 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.98 | 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.46 | 18055864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.14 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.28 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.62 | 19784758 12587719 12969438 19460945 16611625 11587558 16610002 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.22 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.37 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.37 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.09 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.36 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.26 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.83 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
4.91 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.91 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.91 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
tipifarnib |
4.91 | 16885199 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.40 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.75 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.57 | 11731420 19196722 14580682 19196723 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
tipifarnib |
6.57 | 16648579 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.55 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.38 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.38 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.17 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.55 | 19513568 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.11 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.17 | 18803445 18765137 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.33 | 18172295 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.01 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.47 | 18608210 19157545 19010910 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.47 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.85 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.54 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.51 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.70 | 19470736 17925555 19116145 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.00 | 19189210 19200415 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.20 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.11 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.85 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.41 | 16049721 12819281 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.77 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.64 | 19259094 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.37 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.76 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.67 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.12 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.50 | 11550810 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.39 | 18007984 18929643 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.44 | 11896295 11118676 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.44 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.71 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.16 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.30 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.54 | 11422049 12752131 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.21 | 18579056 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.92 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.92 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.89 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.89 | 16876388 1511512 11738929 3137016 14763951 11044598 15475178 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.03 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.56 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.56 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.03 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.76 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.54 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.60 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.13 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.31 | 17967635 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.23 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.51 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.30 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.30 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.30 | 8653321 17572228 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.63 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.31 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.96 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.28 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.91 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.52 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |